SCHEMBL5047724

SCHEMBL5047724

N#Cc1ccc2cc(CCN3CCC(NC(=O)O)CC3)c(=O)[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.46
DRD3 P35462 4/20 0.46
TP53 P04637 1/20 0.43
HTT P42858 1/20 0.43
CHEK1 O14757 1/20 0.42
KCNH2 Q12809 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
IDH1 O75874 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
DRD4 P21917 1/20 0.40
PIP5K1C O60331 1/20 0.40
PARP1 P09874 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4444391 0.87 TP53 (0.40) DRD2DRD3TP53HTTCHEK1
SCHEMBL5048771 0.83 KCNH2 (0.46) DRD2DRD3KCNH2PARP1PRKAA2
SCHEMBL3846224 0.81 PARP1 (0.46) DRD2DRD3CHEK1KCNH2KDM4E
SCHEMBL4755013 0.76 PARP1 (0.44) DRD2DRD3TP53HTTCHEK1
SCHEMBL4441167 0.76 PARP1 (0.44) DRD2DRD3TP53HTTCHEK1
SCHEMBL3587044 0.76 KCNH2 (0.60) DRD2DRD3KCNH2ADRA1DADRA1A
SCHEMBL921237 0.74 KCNH2 (0.63) DRD2DRD3KCNH2KDM4EHSD17B10
SCHEMBL22374591 0.72 HTR1A (0.59)
SCHEMBL3716513 0.72 IDH1 (0.50) DRD2DRD3KDM4EHSD17B10SMN1; SMN2
SCHEMBL4438705 0.69 PARP1 (0.41) DRD2DRD3TP53HTTCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893599-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006134378-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2006-12-21 WO disclosed